← Back to Search

Transcranial Direct Current Stimulation

Transcranial direct current stimulation (high-definition) for Stroke

N/A
Recruiting
Research Sponsored by University of Oklahoma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (initial visit), before (within 30 min range) and immediately after (within 30 mins range) the intervention
Awards & highlights

Study Summary

This trial will test whether a targeted brain stimulation called HD-tDCS can help reduce muscle synergy impairment, which is a major limitation to the recovery of independent function after a stroke.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (initial visit), before (within 30 min range) and immediately after (within 30 mins range) the intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (initial visit), before (within 30 min range) and immediately after (within 30 mins range) the intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in a subset of Fugl-Meyer Upper Extremity assessment which is mainly related to the muscle synergies
Secondary outcome measures
Change in Transcranial magnetic stimulation (TMS)-evoke motor-evoked potentials (MEP)
Other outcome measures
Change in Brain symmetry index

Trial Design

3Treatment groups
Experimental Treatment
Group I: Sham stimulationExperimental Treatment1 Intervention
Sham stimulation to the brain
Group II: Cathodal stimulationExperimental Treatment1 Intervention
Cathodal one at the contralesional hemisphere
Group III: Anodal stimulationExperimental Treatment1 Intervention
Anodal stimulation targeting hemisphere

Find a Location

Who is running the clinical trial?

Oklahoma Shared Clinical and Translational ResourcesUNKNOWN
1 Previous Clinical Trials
32 Total Patients Enrolled
University of OklahomaLead Sponsor
455 Previous Clinical Trials
95,644 Total Patients Enrolled
3 Trials studying Stroke
84 Patients Enrolled for Stroke
~4 spots leftby Jun 2025